Glory Biotech Co Ltd (4187)

TPEX
Currency in TWD
11.70
0.00(0.00%)
Closed·
Showing Glory Biotech historical data. For real-time data please try another search
Day's Range
11.6211.94
52 wk Range
0.0011.94
Key Statistics
Edit
Bid/Ask
11.62 / 12.21
Prev. Close
11.7
Open
11.9
Day's Range
11.62-11.94
52 wk Range
0-0
Volume
-
Average Volume (3m)
16.37M
1-Year Change
0%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral

Glory Biotech Company Profile

As of December 29, 2017, Glory Biotech Co., Ltd. was acquired by glac Biotech Co., Ltd. Glory Biotech Co., Ltd., a biotechnology company, engages in the development and production of active pharmaceutical ingredients (APIs), probiotics, health food ingredients, and animal feed ingredients in Taiwan. Its general API products include MPA intermediate and Daptomycin; and under development API products comprise Doxorubicin, Epothilone B, Rapamycin intermediate, CMS, and GLP-1. The company’s probiotics include lactobacillus sporogenes, enterococcus faecalis, streptococcus thermophiles, and bacillus subtilis; and health food products comprise mushroom drinks, antrodia, ganoderma lucidum, and enzymes. In addition, it offers functional and composite probiotic powder products, as well as provides agricultural biological agents that combine the functions of pesticide and fertilizer. In addition, it provides contract research services, such as strain improvement, fermentation process optimization and scale up, and recovery and purification process, as well as develops Synbiotics application; and items of OEM/ODM, including probiotics, genetically engineered microbes, bacillus subtilis, yeast, fungus, and enzymes, as well as API products. Glory Biotech Co., Ltd. was founded in 2000 and is based in Chiayi City, Taiwan.

Earnings

Latest Release
Aug 14, 2017
EPS / Forecast
-0.60 / --
Revenue / Forecast
15.82M / --
EPS Revisions
Last 90 days

4187 Income Statement

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.